Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ocata Therapeutics, Inc.

http://www.ocata.com

Latest From Ocata Therapeutics, Inc.

New Daiichi Structure Strengthens Oncology Focus

Japanese firm creates new US-based global organization that reaffirms strategic focus on oncology as main pillar of mid-term growth.

Business Strategies Cancer

Astellas Targets ALS In Expansion Of Cytokinetics Alliance

Astellas and Cytokinetics are expanding their existing alliance to investigate two candidates against amyotrophic lateral sclerosis, as the Japanese firm looks to build its strategic interests in muscle disease.

Research & Development BioPharmaceutical

Favorable Japan Environment Nurtures Daiichi/CTL Cell Therapy Deal

Daiichi Sankyo's recent deal for Japan rights to a cell therapy agent illustrates the ongoing corporate appetite for assets able to benefit from the country's favorable regulatory framework for such products.

BioPharmaceutical Asia Pacific

Chugai Makes Regenerative Meds Move In Attractive Japan Environment

Chugai is taking concrete steps into the burgeoning regenerative medicine sector in Japan through a new clinical and commercial alliance with a domestic venture for a therapy for knee cartilage disorders.

BioPharmaceutical Japan
See All

Company Information

  • Other Names / Subsidiaries
    • Advanced Cell Technology, Inc.
    • Mytogen, Inc.
UsernamePublicRestriction

Register